메뉴 건너뛰기




Volumn 21, Issue 4 A, 2001, Pages 2597-2600

Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner

Author keywords

Breast cancer; Combination therapy; Docetaxel; Synergism; Tetrahydropyranyladriamycin

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DOCETAXEL; PIRARUBICIN; TAXANE DERIVATIVE;

EID: 0035153471     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (20)
  • 6
    • 0032773188 scopus 로고    scopus 로고
    • Single-agent docetaxel (Taxotere) in randomized phase III trials
    • (1999) Semin Oncol , vol.26 , Issue.3 SUPPL. 9 , pp. 1-6
    • Burris III, H.A.1
  • 7
    • 0032803418 scopus 로고    scopus 로고
    • Docetaxel (Taxotere) plus doxorubicin-based combinations: The evidence of activity in breast cancer
    • (1999) Semin Oncol , vol.26 , Issue.3 SUPPL. 9 , pp. 7-13
    • Nabholtz, J.M.1
  • 18
    • 0032803418 scopus 로고    scopus 로고
    • Docetaxel (Taxotere) plus doxorubicin-based combinations: The evidence of activity in breast cancer
    • (1999) Semin Oncol , vol.26 , pp. 7-13
    • Nabholtz, J.M.1
  • 19
    • 0032790047 scopus 로고    scopus 로고
    • Doxorubicin/taxane combinations: Cardiac toxicity and pharmacokinetics
    • (1999) Semin Oncol , vol.26 , pp. 14-19
    • Sparano, J.A.1
  • 20
    • 0031647014 scopus 로고    scopus 로고
    • Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies
    • (1998) Semin Oncol , vol.25 , pp. 10-15
    • Sparano, J.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.